Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
KENNETH ERLAND JOHNSON Insider Profile
4 Followers
KENNETH ERLAND JOHNSON, SVP, Global Development and Medical Affairs at Xeris Pharmaceuticals, holds 373.04K shares in Xeris Pharmaceuticals (Ticker: XERS).
KENNETH ERLAND JOHNSON Xeris Pharmaceuticals (XERS)SVP, Global Development and Medical Affairs
Xeris Pharmaceuticals (XERS)
SVP, Global Development and Medical Affairs
Ranked #60,592 out of 99,115 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-12.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of KENNETH ERLAND JOHNSON's holdings
Insider Roles
SVP, Global Development and Medical Affairs
Roles that KENNETH ERLAND JOHNSON holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 18, 2020 - Feb 18, 2021
Return:+34.10%
The most profitable trade made by KENNETH ERLAND JOHNSON
KENNETH ERLAND JOHNSON's Trading History
List of latest transactions for each holding click on a transaction to see KENNETH ERLAND JOHNSON's performance on stock
You May Also Like
KENNETH ERLAND JOHNSON insider profile FAQ
What is the percentage of profitable transactions made by KENNETH ERLAND JOHNSON?
The percentage of profitable transactions made by KENNETH ERLAND JOHNSON is 50%.
What is the average return per transaction made by KENNETH ERLAND JOHNSON?
The average return per transaction made by KENNETH ERLAND JOHNSON is -12.90%.
What stocks does KENNETH ERLAND JOHNSON hold?
KENNETH ERLAND JOHNSON holds: XERS stocks.
What was KENNETH ERLAND JOHNSON’s latest transaction?
KENNETH ERLAND JOHNSON latest transaction was an Uninformative Sell of $15.82K.
What was KENNETH ERLAND JOHNSON's most profitable transaction?
KENNETH ERLAND JOHNSON’s most profitable transaction was an Informative Buy of XERS stock on February 18, 2020. The return on the trade was 34.10%.
What is KENNETH ERLAND JOHNSON's role in Xeris Pharmaceuticals?
KENNETH ERLAND JOHNSON's role in Xeris Pharmaceuticals is SVP, Global Development and Medical Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.